| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |